"It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk." People who use these medications and have questions or concerns about side effects should speak with their health care provider, the FDA says
Injectable GLP-1 agonists often rely on structural modifications that extend systemic residence time
See how the compounded semaglutide and tirzepatide telehealth platform works, including its oral gum option, before you sign up
Your success is our success
Consider choosing a provider that offers: Medical weight loss programs for sustainable, physician-guided weight management Hormone replacement therapy (HRT) for men and women experiencing fatigue, mood changes, or hormonal imbalances IV infusion therapy for hydration, energy, and immune support Mental health services , including GeneSight testing for personalized psychiatric medication management Having access to these services in one location means less running around and more streamlined, convenient care